13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001892688-23-000045
Total Value
$119.9M
Positions
13
Other Managers
1
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 3,136,173 | $24.2M | 20.18% |
| 2 | CABALETTA BIO INC | CABA | 2,454,627 | $20.3M | 16.92% |
| 3 | MERUS N V | N5749R100 | 1,067,723 | $19.6M | 16.38% |
| 4 | KINNATE BIOPHARMA INC | 49705R105 | 2,214,250 | $13.8M | 11.54% |
| 5 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,369,927 | $11.9M | 9.96% |
| 6 | PIERIS PHARMACEUTICALS INC | 720795103 | 7,067,718 | $6.9M | 5.75% |
| 7 | THESEUS PHARMACEUTICALS INC | 88369M101 | 761,258 | $6.8M | 5.64% |
| 8 | BELLUS HEALTH INC NEW | 07987C204 | 866,646 | $6.2M | 5.20% |
| 9 | PARDES BIOSCIENCES INC | 69945Q105 | 3,324,061 | $4.4M | 3.66% |
| 10 | PASSAGE BIO INC | PASG | 3,407,598 | $3.3M | 2.72% |
| 11 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 2,428,323 | $1.7M | 1.42% |
| 12 | STRUCTURE THERAPEUTICS INC | GPCR | 23,000 | $547,170 | 0.46% |
| 13 | PHARVARIS N V | PHVS | 26,225 | $211,242 | 0.18% |